205 related articles for article (PubMed ID: 34798856)
1. Clinicopathological features, clinical efficacy on 101 cases of rectal gastrointestinal stromal tumors, and the significance of neoadjuvant therapy.
Yang H; Shen C; Yin X; Cai Z; Wang Q; Zhang B
BMC Surg; 2021 Nov; 21(1):400. PubMed ID: 34798856
[TBL] [Abstract][Full Text] [Related]
2. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
Yang W; Liu Q; Lin G; Zhang B; Cao H; Zhao Y; Xia L; Feng F; Xiong Z; Hu J; Ye Y; Tao K; Zhang P
J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
4. Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
Kaneko M; Nozawa H; Emoto S; Murono K; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Watanabe T
Anticancer Res; 2017 Sep; 37(9):5155-5160. PubMed ID: 28870948
[TBL] [Abstract][Full Text] [Related]
5. Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors.
Cheong C; Kang J; Min BS; Kim NK; Ahn JB; Lee KY
PLoS One; 2022; 17(9):e0270887. PubMed ID: 36084094
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Rectal Gastrointestinal Stromal Tumor(GIST)Treated with Imatinib Mesylate Neoadjuvant Therapy to Preserve the Anus].
Kenno S; Inagaki M; Funakoshi T; Yanagida N; Akabane H; Nakano S; Sato K
Gan To Kagaku Ryoho; 2018 Jun; 45(6):981-984. PubMed ID: 30026427
[TBL] [Abstract][Full Text] [Related]
7. Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature.
Sun Q; Su N; Li X; Hu Z; Wang W
Asia Pac J Clin Oncol; 2020 Jun; 16(3):123-128. PubMed ID: 31957191
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor.
Hou YY; Zhou Y; Lu SH; Qi WD; Xu C; Hou J; Tan YS
World J Gastroenterol; 2009 Apr; 15(15):1910-3. PubMed ID: 19370794
[TBL] [Abstract][Full Text] [Related]
9. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
[TBL] [Abstract][Full Text] [Related]
10. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis.
Wang J; Yin Y; Shen C; Yin X; Cai Z; Pu L; Fu W; Wang Y; Zhang B
Medicine (Baltimore); 2020 Feb; 99(9):e19275. PubMed ID: 32118738
[TBL] [Abstract][Full Text] [Related]
11. Worse Outcome with Imatinib Mesylate as Neoadjuvant Therapy in Locally Advanced Rectal Gastrointestinal Stromal Tumors: Case Series of Four Patients.
Amaadour L; Berrad S; Oualla K; Benbrahim Z; Arifi S; Mellas N
Gulf J Oncolog; 2022 May; 1(39):27-30. PubMed ID: 35695343
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Local Resection for Rectal GIST Following Neoadjuvant Imatinib Mesylate Treatment].
Yoshioka Y; Tokoro T; Ushijima H; Daito K; Kawamura J; Ueda K; Hida J; Okuno K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1997-1999. PubMed ID: 29394846
[TBL] [Abstract][Full Text] [Related]
13. Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.
Ling JY; Ding MM; Yang ZF; Zhao YD; Xie XY; Shi LS; Wang HM; Cao WT; Zhang JW; Hu HB; Cai Y; Wang H; Deng YH
J Surg Oncol; 2021 Dec; 124(8):1442-1450. PubMed ID: 34494280
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological features and prognostic factors of gastric intermediate-risk gastrointestinal stromal tumor after surgical resection: a retrospective study].
Yuan W; Huang W; Ren L; Liang HY; Du XY; Fu M; Xu C; Fang Y; Shen KT; Hou YY
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):384-389. PubMed ID: 36973200
[No Abstract] [Full Text] [Related]
15. [Transanal endoscopic microsurgery for local excision of rectal gastrointestinal stromal tumors].
Wu X; Lin G; Qiu H; Zhou J; Xu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1296-1300. PubMed ID: 30506543
[TBL] [Abstract][Full Text] [Related]
16. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
Qi J; Liu HL; Ren F; Liu S; Shi W; Liu WH; Cai GQ; Liao GQ
World J Surg Oncol; 2020 Apr; 18(1):70. PubMed ID: 32264886
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor.
Cavnar MJ; Seier K; Gönen M; Curtin C; Balachandran VP; Tap WD; Antonescu CR; Singer S; DeMatteo RP
J Gastrointest Surg; 2021 Jul; 25(7):1828-1836. PubMed ID: 33169327
[TBL] [Abstract][Full Text] [Related]
18. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
[TBL] [Abstract][Full Text] [Related]
19. Initial application of transanal endoscopic microsurgery for high-risk lower rectal gastrointestinal stromal tumor after imatinib mesylate neoadjuvant chemotherapy: A case report.
Liu Q; Zhong G; Zhou W; Lin G
Medicine (Baltimore); 2017 Jul; 96(29):e7538. PubMed ID: 28723770
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of surgical and imatinib treatment for rectal gastrointestinal stromal tumours: retrospective cohort study.
Tsukamoto S; Honma Y; Shoji H; Hirano H; Inoue M; Takamizawa Y; Moritani K; Imaizumi J; Kanemitsu Y
BJS Open; 2022 May; 6(3):. PubMed ID: 35594280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
